These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19918272)

  • 21. Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy.
    Colebatch AN; Mounce KE
    J Clin Rheumatol; 2010 Mar; 16(2):74-5. PubMed ID: 20130477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
    Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
    J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case report: Mycobacterium bovis orchitis post intravesical Bacillus Calmette Guerin.
    Samannodi M; Villavicencio A; Zhao A; Chavez V; Ericsson CD
    IDCases; 2018; 14():e00465. PubMed ID: 30479960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
    Hudson MA; Yuan JJ; Catalona WJ; Ratliff TL
    J Urol; 1990 Dec; 144(6):1362-4. PubMed ID: 2231927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculous Psoas Abscess and Worsening Vascular Aneurysm; All from Bacillus Calmette-Guerin (BCG) Therapy?
    Okon E; Stearns J; Durgam AK
    Am J Case Rep; 2017 Jul; 18():810-812. PubMed ID: 28720750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
    Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
    J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of synchronous bilateral epididymal and testicular metastases of urothelial carcinoma of the bladder after intravesical bacillus Calmette-Guérin.
    Nishiyama N; Ikehata Y; Okuno N; Sasahara M; Sakamaki I; Yamamoto Y; Kitamura H
    Int Cancer Conf J; 2021 Jan; 10(1):59-62. PubMed ID: 33489703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated Bacillus Calmette-Guérin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guérin Therapy.
    Curley M; Bhardwaj H
    Clin Nucl Med; 2020 Jul; 45(7):e323-e324. PubMed ID: 32433172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miliary tuberculosis following intravesical Bacillus Calmette and Guérin therapy: A rare complication of a frequent procedure.
    Loued L; Fahem N; Kaddoussi R; Abdelaaly M; Cheikh Mhamed S; Rouatbi N
    Urol Case Rep; 2021 Sep; 38():101655. PubMed ID: 33868941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacillus Calmette-Guérin strain differences as the basis for immunotherapies against bladder cancer.
    Miyazaki J; Onozawa M; Takaoka E; Yano I
    Int J Urol; 2018 May; 25(5):405-413. PubMed ID: 29506322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of miliary tuberculosis following transurethral surgery and prostate biopsy after intravesical Bacillus Calmette-Guerin immunotherapy.
    Kurokawa Y; Kawai T; Miyakawa J; Makise N; Akiyama Y; Yamada Y; Sato Y; Yamada D; Ushiku T; Kume H
    IJU Case Rep; 2022 Jan; 5(1):45-47. PubMed ID: 35005471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
    Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
    Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
    Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G
    Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR; Torrence RJ; Gillen DP; Hudson MA; Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy.
    Minakata T; Nakano Y; Tamura S; Kazuki Y; Hayakawa K; Hayakawa T; Oota T; Fuzimoto T; Yamano Y; Takii T
    Intern Med; 2020; 59(5):733-737. PubMed ID: 32115520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
    Kudo T; Iwasa N; Maeda S; Mitarai S
    Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
    Yokomizo A; Kanimoto Y; Okamura T; Ozono S; Koga H; Iwamura M; Tanaka H; Takahashi S; Tsushima T; Kanayama HO; Akaza H; Shinohara N; Mugiya S; Nomata K; Nakamura T; Naito S
    J Urol; 2016 Jan; 195(1):41-6. PubMed ID: 26307162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vertebral Osteomyelitis Secondary to Bacillus Calmette-Guérin Instillation Therapy for Transitional Cell Carcinoma In Situ.
    Jaber TM; Samiullah M; Surti A
    Cureus; 2021 Apr; 13(4):e14589. PubMed ID: 34036007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.